SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015996
Filing Date
2021-11-15
Accepted
2021-11-15 16:26:14
Documents
125
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aytu-20210930x10q.htm   iXBRL 10-Q 1924443
2 EX-10.2 aytu-20210930xex10d2.htm EX-10.2 43064
3 EX-10.3 aytu-20210930xex10d3.htm EX-10.3 30204
4 EX-31.1 aytu-20210930xex31d1.htm EX-31.1 15272
5 EX-31.2 aytu-20210930xex31d2.htm EX-31.2 14111
6 EX-32.1 aytu-20210930xex32d1.htm EX-32.1 14812
7 GRAPHIC aytu-20210930x10q001.jpg GRAPHIC 2574
  Complete submission text file 0001558370-21-015996.txt   11653325

Data Files

Seq Description Document Type Size
8 EX-101.SCH aytu-20210930.xsd EX-101.SCH 91757
9 EX-101.CAL aytu-20210930_cal.xml EX-101.CAL 100960
10 EX-101.DEF aytu-20210930_def.xml EX-101.DEF 352736
11 EX-101.LAB aytu-20210930_lab.xml EX-101.LAB 798158
12 EX-101.PRE aytu-20210930_pre.xml EX-101.PRE 668845
13 EXTRACTED XBRL INSTANCE DOCUMENT aytu-20210930x10q_htm.xml XML 2402589
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38247 | Film No.: 211411154
SIC: 2834 Pharmaceutical Preparations